Home Search
xolair - search results
If you're not happy with the results, please do another search
Six Facts to Know About Xolair for Food Allergies
This week, the FDA approved Xolair for the treatment of food allergies. Here's a slideshow featuring six important facts to know about this new...
FDA Approves Xolair for Children and Adults With One or More Food Allergies
A significantly higher proportion of food allergy patients as young as 1 year treated with Xolair could tolerate small amounts of peanut, milk, egg and cashew without an allergic reaction, compared to placebo.
FDA Grants Xolair Priority Review for Children and Adults with Food Allergies
If approved, Xolair would be the first medicine to reduce allergic reactions to multiple foods following an accidental exposure.
Study: Omalizumab (Xolair) May Help Treat Idiopathic Anaphylaxis
Small study finds drug may be effective in treating IA.
FDA Grants Xolair Breakthrough Therapy Designation for Food Allergies
Breakthrough Therapy Designation was granted on the basis of data from seven clinical studies assessing the efficacy and safety of Xolair against a range of food allergens including peanut, milk, egg and others.
Bacon Safe for Alpha-Gal? Peanuts Safe for Peanut Allergy? GMOs in the News
Genetically modified alternatives are here, like it or not.
Biologic Showing Promise as Food Allergy Treatment in Ongoing Phase 3 Trial
Assessment for both single agent and add-on therapy.
United Biopharma’s Monoclonal Antibody Shows Promise in Neutralizing IgE
Shows promise for the treatment of chronic spontaneous urticaria, food allergies, asthma and eczema.
Clinical Trial to Evaluate Experimental Treatment in People Allergic to Multiple Foods
NIH and partners to assess whether Omalizumab can reduce allergic reactions.
OIT is a Therapy, Not an Ideology
The decisions we all face as patients and caretakers depend on the individual, their allergies, their lifestyles and myriad other factors.